CONSUN PHARMA (01681) has cancelled 100,000 shares of repurchased shares.
Kangson Pharmaceutical (01681) announced that on February 12, 2026, the company had cancelled 100,000 repurchased shares.
CONSUN PHARMA (01681) announced that on February 12, 2026, the company has cancelled 100,000 repurchased shares.
Related Articles
HK Stock Market Move | HEALTHYWAY INC(02587) rose more than 14% after the earnings, with expected annual profit no less than 50 million RMB. AI software products have contributed 30 million RMB in revenue.
New stock first day | "Picture fusion first stock" Haizhi Technology (02706) first listed on the market surged more than 225%, 5065 times oversubscribed to ignite the market.
On the first day of trading, Shenzhen Woer Heat-shrinkable Material (09981) debuted and opened 0.05% higher in the morning session. The company is ranked fifth among global communication cable manufacturers.
HK Stock Market Move | HEALTHYWAY INC(02587) rose more than 14% after the earnings, with expected annual profit no less than 50 million RMB. AI software products have contributed 30 million RMB in revenue.
New stock first day | "Picture fusion first stock" Haizhi Technology (02706) first listed on the market surged more than 225%, 5065 times oversubscribed to ignite the market.
On the first day of trading, Shenzhen Woer Heat-shrinkable Material (09981) debuted and opened 0.05% higher in the morning session. The company is ranked fifth among global communication cable manufacturers.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
